Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› EGFR exon 20
EGFR exon 20
(1 companies · 1 programs)
Companies with an active program directed at EGFR exon 20.
Oric Pharmaceuticals, Inc.
ORIC
enozertinib
— Non-Small Cell Lung Cancer
Phase 1